Dr. Barbara Vanderhyden has dedicated her career to unlocking the mysteries of cancer and developing new ways to treat the disease. Now, she’s celebrating an exciting breakthrough in her research, thanks in part to your support.
“We just completed a small preclinical trial,” says Dr. Vanderhyden, “and it is showing that the immunotherapy we designed for ovarian cancer is working very well.”
Two years ago, immunotherapy treatments were virtually unavailable. Today, it has seen great advancements and has researchers and doctors alike excited. Immunotherapy drugs activate a person’s immune system to destroy cancer cells.
It’s a major step forward in cancer treatment. The immune system evolves, so as the cancer mutates to fool the therapy, the immune system can sustain its attack.
For Dr. Vanderhyden, the goal is eventually to try and use the new treatment in combination with oncolytic viruses. “This is a really exciting time for our lab. If this new antibody treatment works, then we should be able to try it in all different types of cancers.”